⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31319920 | 0.77 | — | — | |
| SCHEMBL21247921 | 0.65 | — | — | |
| SCHEMBL6666128 | 0.64 | — | — | |
| SCHEMBL2357367 | 0.64 | — | — | |
| SCHEMBL16160994 | 0.64 | — | — | |
| SCHEMBL1982688 | 0.64 | — | — | |
| SCHEMBL35210236 | 0.64 | — | — | |
| SCHEMBL24243502 | 0.61 | — | — | |
| SCHEMBL1261763 | 0.58 | — | — | |
| SCHEMBL6915854 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727653-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4727655-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4727654-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260077017-A1 | ADRENOMEDULLIN ANALOGS AND METHODS OF USE THEREOF | UNIV LELAND STANFORD JUNIOR (US) | 2026-03-19 | — | — | US | disclosed |
| US-20250296959-A1 | B7-H3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | MARIANA ONCOLOGY INC (US) | 2025-09-25 | — | — | US | disclosed |
| US-20250205373-A1 | ENRICHED AND STABLE RADIOLIGAND THERAPY FORMULATIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | MARIANA ONCOLOGY INC (US) | 2025-06-26 | — | — | US | disclosed |
| US-20250186541-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | MARIANA ONCOLOGY INC (US) | 2025-06-12 | — | — | US | disclosed |
| WO-2025122615-A1 | ENRICHED AND STABLE RADIOLIGAND THERAPY FORMULATIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | MARIANA ONCOLOGY INC. (US) | 2025-06-12 | — | — | WO | disclosed |
| EP-4565258-A2 | COMPOSITIONS FOR THE TREATMENT OF DISEASE | Sightstream Biotherapeutics, Inc. (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20250179691-A1 | MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO CARBOHYDRATE-BINDING MONOCLONAL ANTIBODY FAMILY PGT128 | BRANDEIS UNIVERSITY (US) | 2025-06-05 | — | — | US | disclosed |
| US-20170137468-A1 | MODULATION OF COMPLEMENT ACTIVITY | UCB HOLDINGS, INC. | 2017-05-18 | — | — | US | disclosed |
| EP-3154561-A2 | MODULATION OF COMPLEMENT ACTIVITY | RA Pharmaceuticals, Inc. (US) | 2017-04-19 | — | — | EP | disclosed |
| WO-2016123371-A1 | MODULATORS OF COMPLEMENT ACTIVITY | RA PHARMACEUTICALS, INC. (US) | 2016-08-04 | — | — | WO | disclosed |
| WO-2015191951-A2 | MODULATION OF COMPLEMENT ACTIVITY | RA PHARMACEUTICALS, INC. (US) | 2015-12-17 | — | — | WO | disclosed |
| US-6046197-A | NON-PEPTIDE AMIDE COMPOUNDS; STIMULATE HEMATOPOIESIS AND MAY BE USEFUL FOR TREATMENT OF VIRAL, FUNGAL AND BACTERIAL INFECTIOUS DISEASES | SMITHKLINE BEECHAM CORPORATION (US) | 2000-04-04 | — | — | US | disclosed |
| EP-0989136-A1 | PEPTIDES HAVING CYCLIC STRUCTURES AND EXERTING P53 PROTEIN ACTIVTY-RESTORING EFFECT ON P53 PROTEIN MUTANTS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2000-03-29 | — | — | EP | disclosed |
| US-5530139-A | BENZO- AND NAPHTHOTHIOPHENE COMPOUNDS; INTERMEDIATES IN AGRICULTURE, FOODS AND MEDICINE, MONOMER FOR ELECTROCONDUCTIVE POLYMER | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1996-06-25 | — | — | US | disclosed |
| EP-0421436-A2 | Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity | WARNER-LAMBERT COMPANY (US) | 1991-04-10 | — | — | EP | disclosed |
| US-4925770-A | COATING, PRIOR TO LIGHT EXPOSURE OF PHOTORESIST LAYER, A PHOTO-BLEACHABLE COMPOUND AND A WATER SOLUBLE POLYMER | DIRECTOR GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1990-05-15 | — | — | US | disclosed |
| EP-0246885-A2 | A contrast-enhancing agent for photolithography | Japan as represented by Director-General, Agency of Industrial Science and Technology (JP) | 1987-11-25 | — | — | EP | disclosed |